Successful Treatment Using Apixaban in a Patient on Hemodialysis with Uremic Calciphylaxis

Clin Cosmet Investig Dermatol. 2022 Oct 28:15:2329-2333. doi: 10.2147/CCID.S382503. eCollection 2022.

Abstract

Calciphylaxis is a rare but serious condition in which microvessel occlusion occurs within the subcutaneous adipose tissue and dermis, leading to painful lesions. End-stage renal disease requiring hemodialysis and warfarin therapy can increase the risk of calciphylaxis. In this report, we describe the evaluation and treatment of a 75-year-old female patient with warfarin-induced calciphylaxis who presented unique symptoms. The patient required intensive care unit admission due to hemodynamic instability, which was treated with inotropes and broad-spectrum intravenous antibiotics. This description of the patient's unusual symptoms has the potential to provide insights needed to improve the diagnosis of future patients. Due to the unavailability of FDA-approved treatment for calciphylaxis, its management is based on data from observational studies and clinical experience.

Keywords: calciphylaxis; case report; ischemia; meropenem; warfarin.

Publication types

  • Case Reports

Grants and funding

This research was funded by King Abdullah International Medical Research Center, Jeddah, Saudi Arabia.